Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Sarcopenia causes several adverse events in elderly people. Muscle fibre atrophy and interstitial fibrosis are the main histopathological changes in sarcopenia and account for decreased muscle function. Tribbles homologue 3 (TRB3) was previously reported to exhibit age‐related expression and play a vital role in cell proliferation, differentiation, and fibrosis. We aimed to investigate how TRB3 affects sarcopenia.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Wild‐type and TRB3 knockout C57/BL6J mice were randomly divided into young and old groups. Exercise capacity was evaluated, and single‐muscle function was detected by electrophysiological techniques, after which the mice were sacrificed to collect their gastrocnemius muscles for assessment of atrophy and fibrosis by histopathological and molecular biological methods. TRB3 expression, autophagy level, and MAPK signalling pathway activity were evaluated through western blotting. The interaction of TRB3 with P62 and the association between TRB3 and the MAPK signalling pathway were detected by co‐immunoprecipitation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>In aged mice, exercise capacity and cross‐sectional area of skeletal muscle fibres were decreased significantly, whereas TRB3, atrophy‐related markers atrogin 1 and MuRF 1, and interstitial fibrosis, including collagen volume fraction, contents of collagens I and III, and ratio of collagens I to III, were increased significantly (<i>P</i> < 0.05 for all). Following TRB3 knockout, the cross‐sectional area of muscle fibres, mainly fast fibres, was elevated (<i>P</i> < 0.05 for both), the atrogin 1 expression was decreased (<i>P</i> = 0.0163), and the corresponding tetanic force of fast muscles was increased (<i>P</i> = 0.0398). Conversely, interstitial fibrosis was substantially decreased and exercise capacity was significantly increased in the knockout mice. In terms of the underlying mechanisms, the autophagy receptor p62 was markedly increased and the MAPK signalling pathway was activated in aged skeletal muscles, which might be attributed to the interaction of TRB3 with p62 and MAPKKs, including MEK1/MEK2, MEK3/MEK6, and MEK4/MKK4. Notably, TRB3 knockout reduced the accumulation of p62 and LC3 (<i>P</i> < 0.05 for both), decreased the phosphorylation of JNK (<i>P</i> = 0.0015), and increased p38 phosphorylation (<i>P</i> = 0.0021). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>TRB3 knockout in mice attenuated muscle fibre atrophy and reduced skeletal muscle fibrosis by increasing autophagy and inhibiting the MAPK signalling pathway. Correspondingly, in aged knockout mice, exercise capacity was improved. Interfering with TRB3 expression in aged skeletal muscles may serve as a target for the prevention and treatment of age‐related sarcopenia.</p></section>

AAV1.NT‐3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia

AAV1.NT-3 gene therapy prevents age-related sarcopenia

Improvement of muscular atrophy by AAV-SaCas9-mediated myostatin gene editing in aged mice

AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice

Age Related Changes in Muscle Mass and Force Generation in the Triple Transgenic (3xTgAD) Mouse Model of Alzheimer’s Disease

Deletion of Sod1 in motor neurons exacerbates age-related changes in axons and NMJs associated with premature muscle atrophy in aging mice

Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia

AAV-Mediated Nuclear Localized PGC14 Delivery in Muscle Ameliorates Sarcopenia and Aging-Associated Metabolic Dysfunctions

AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions

The lack of CuZnSOD leads to impaired neurotransmitter release, neuromuscular junction destabilization and reduced muscle strength in mice

TRIM16 facilitates SIRT‐1‐dependent regulation of antioxidant response to alleviate age‐related sarcopenia

Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice

Identification of nicotinamide N‐methyltransferase as a promising therapeutic target for sarcopenia

Senolytic treatment does not mitigate oxidative stress-induced muscle atrophy but improves muscle force generation in CuZn superoxide dismutase knockout mice

Synergistically Acting on Myostatin and Agrin Pathways Increases Neuromuscular Junction Stability and Endurance in Old Mice

Automated rodent in situ muscle contraction assay and myofiber organization analysis in sarcopenia animal models.

Sarcopenia is attenuated by TRB3 knockout in aging mice via the alleviation of atrophy and fibrosis of skeletal muscles

Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending Shield

Neuroprotective treatment with the nitrone compound OKN-007 mitigates age-related muscle weakness in aging mice

Endurance Training Inhibits the JAK2/STAT3 Pathway to Alleviate Sarcopenia

Pathological Sequelae Associated with Skeletal Muscle Atrophy and Histopathology in G93A*SOD1 Mice